MODERN VISION OF DEVELOPMENT FACTORS OF PROTEIN-ENERGY MALNUTRITION SYNDROME IN PATIENTS, RECEIVING PERITONEAL DIALYSIS

Abstract

Patients who have end-stage chronic kidney disease (СKD) and who receive substitutive peritoneal dialysis (PD) therapy, often have complication such as protein-energy malnutrition syndrome (PEMS). Important prognostic value is given to nutritional disorders as they increase prior disease development, complicate its correction, influence survival rate of patients of this category. Purpose: to explore prevalence of protein-energy malnutrition syndrome in PD patients and define factors of its development. Materials and methods: 67 PD patients were examined. Evaluation of nutritional status in patients under investigation was made using development of complex methodology that includes 5 specifications – body mass index (BMI), triceps skinfold, arm circumference – biceps, floating albumin and seraalbumin, absolute number of lymphocyte. Results. PEMS was found in 35,8% of patients, 29,8% had mild case and 6% had moderate case with mixed form domination. 26,8% of PD patients had average high or high transport characteristics of abdominal membrane that provided increased protein loss through abdominal membrane on PD. It was determined that with the growth of С-reactive protein (CRP) level nutritional disorders increased. In our research chronic inflammation syndrome was found in 16,3% of cases. Besides, protein loss was growing fast after another dialysis peritonitis. Expressed deficit of daily consumption of protein was registered in 29,2% of patients. Conclusion. Our researches analysis allowed us to define that risk factors of formation of protein metabolism disorders in PD patients are low protein consumption, connection with nutritional deficiency syndrome, system inflammatory reaction, protein loss with dialysis fluid having high transport characteristics of abdominal membrane and repeated dialysis peritonitis.

Authors and Affiliations

V. Lesovoy, N. Andonieva, M. Dubovik, E. Huts

Keywords

Related Articles

Metabolism oxalic acid: failure causes and consequences of molecular-biochemical factors for the formation of oxalate-induced diseases

Mechanisms mediating oxalate-induced alterations in renal have attracted the attention of scientists in recent years.Various mechanisms have been proposed to explain crystal retention. The present review assesses the bio...

INFLUENCE OF SECONDARY HYPERPARATHYROIDISM ON THE CALCIFICATION OF HEART VALVES IN PATIENTS WITH CHRONIC KIDNEY DISEASE VD STAGE

The aim of this work was to study the relationship of elevated levels of parathyroid hormone (PTH) with cardiovascular changes (calcification of the heart valves) and to identify possible risk factors of calcification in...

HELLP syndrome against the background of glomerulonephritis: Clinical casereport

HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) is a severe and rapidly progressing condition that requires distinct diagnostic considerations. The clinical presentation varied within all of the cla...

Вміст васкулоендотеліального фактору росту в сироватці крові хворих на цукровий діабет 2 типу залежно від функціонального стану нирок

Мета роботи: визначення вмісту васкулоендотеліального фактору росту (VEGF) в сироватці крові хворих на цукровий діабет (ЦД) 2 типу в залежності від функціонального стану нирок.Матеріал та методи: було обстежено 66 хворих...

Використання подвійного J-стенту у реципієнтів ниркового трансплантату: звіт про когорту одного центру

Трансплантація нирок є методом вибору для лікування термінальної стадії хронічної хвороби нирок. Подвійний J стент зазвичай використовується під час трансплантації нирок. Частота урологічних ускладнень коливається в межа...

Download PDF file
  • EP ID EP353216
  • DOI 10.31450/ukrjnd.3(55).2017.08
  • Views 95
  • Downloads 0

How To Cite

V. Lesovoy, N. Andonieva, M. Dubovik, E. Huts (2017). MODERN VISION OF DEVELOPMENT FACTORS OF PROTEIN-ENERGY MALNUTRITION SYNDROME IN PATIENTS, RECEIVING PERITONEAL DIALYSIS. УКРАЇНСЬКИЙ ЖУРНАЛ НЕФРОЛОГІЇ ТА ДІАЛІЗУ, 3(55), 72-75. https://europub.co.uk/articles/-A-353216